US Drug Recall Register

FDA Drug Recalls

2,277 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Clobetasol Propionate Ointment

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0795-2023
Class II · Moderate risk Ongoing

Clobetasol Propionate Cream

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0794-2023
Class II · Moderate risk Ongoing

Cimetidine HCl Oral Solution 300mg/5mL

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0793-2023
Class II · Moderate risk Ongoing

Ciclopirox Topical Solution 8%

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0792-2023
Class II · Moderate risk Ongoing

Cetrorelix Acetate for Injection

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0791-2023
Class II · Moderate risk Ongoing

Calcitriol Injection 1 mcg/mL

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0790-2023
Class II · Moderate risk Ongoing

Calcipotriene Topical Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0789-2023
Class II · Moderate risk Ongoing

Ak-Poly-Bac

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0788-2023
Class II · Moderate risk Ongoing

Azelastine Hydrochloride Nasal Spray

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0787-2023
Class II · Moderate risk Ongoing

Artificial Tears Ointment

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0786-2023
Class II · Moderate risk Ongoing

Artificial Tears Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0785-2023
Class II · Moderate risk Ongoing

Apraclonidine Ophthalmic Solution 0.5%

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0784-2023
Class II · Moderate risk Ongoing

Albuterol Sulfate Syrup

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0783-2023
Class II · Moderate risk Ongoing

Acyclovir Oral Suspension

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0782-2023
Class II · Moderate risk Ongoing

Acetic Acid Otic Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0781-2023
Class II · Moderate risk Ongoing

Atropine Sulfate Ophthalmic Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0779-2023
Class II · Moderate risk Ongoing

C-Semaglutide 5mg/mL injection

Reason Lack of assurance of sterility.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0538-2023
Class II · Moderate risk Ongoing

Admelog

Reason Lack of Assurance of Sterility: Malformed crimped collar seal

Sanofi-Aventis U.S. LLC NDC 0024-5926-05 D-0575-2023
Class II · Moderate risk Ongoing

Fast Acting Earwax Removal System

Reason CGMP Deviations: active ingredient may be subpotent before the labeled expiry due to degradation.

Pharma Nobis LLC D-0537-2023
Class II · Moderate risk Ongoing

Advil Ibuprofen Tablets

Reason CGMP deviation: product outside labeled storage temperature requirements.

Family Dollar Stores, Llc. D-0564-2023
Class II · Moderate risk Ongoing

Advil Ibuprofen Tablets

Reason CGMP deviation: product outside labeled storage temperature requirements.

Family Dollar Stores, Llc. D-0563-2023